Program
OCTOBER 24th - LEÓN: mAbxience Facility Visit
Julia Morros s/n, Armunia. LEÓN (SPAIN)
6:58 – 8:59h.
Departure time from Chamartín train station (Madrid-León)*
9:30 – 13:30h.
mAbxience presentation and facility visit**
Luis Fontanetti. Site Director Genhelix (mAbxience León)
13:30h. – 14:30h.
Lunch time
14:30h. – 16:30h.
Guided tour of León (optional)
17:11h.
Return time from León train stations (León-Madrid)*
*Train tickets not included. Timetable subject to possible changes by Renfe
**Various groups
OCTOBER 25th - MADRID: III Biosimilars Forum 2024
Castellana 81. MADRID (SPAIN)
8:30 – 9:00h.
Registration
9:00 – 9:10h.
Opening and mAbxience Perspectives
A brief welcome and forum objectives by Jurgen Van Broeck, CEO of mAbxience
9:10 – 9:30h.
The basics of biosimilars: evidence of similarity
Chairman III Biosimilars Forum: Fernando de Mora
PhD, Professor of Pharmacology, International Academic Speaker &
Consultant on Biosimilars - Universidad Autónoma de Barcelona
9:30 – 10:00h.
R&D. Denosumab biosimilar: structural and functional analytical similarity
Speaker: Daniel Sacristán, PhD, R&D CMC Manager of mAbxience
10:00 – 11:00h.
ROUND TABLE: Biosimilars in the Clinical Practice
Moderator: Fernando de Mora
Participants:
– Eduardo Cioppi, Global Sales Director of mAbxience
– Ana Gutiérrez Casbas, MD, Past President of GETECCU, Head of IBD Unit of HGuniversitary Dr Balmis of Alicante
– Elena Elez, MD, PhD, Medical Oncologist at Vall d’Hebron Institute of Oncology (VHIO)
– Gustavo Milone, MD, Hematologist
11:00 – 11:30h.
Coffee Break and Networking
11:30 – 12:00h.
The biosimilar regulatory framework: present and future
Speaker: Elena Guillen, MD, PhD, Clinical Pharmacologist
12:00 – 12:30h.
How biosimilars can change therapeutic paradigms in oncology
Speaker: Dr. Rosa Giuliani. Oncologist. Guy's Hospital and St Thomas' NHS Foundation Trust, London, UK
12:30 – 13:30h.
Panel Discussion and Q&A Session. Europe experience in biosimilars and its applicability to other regions
Moderator: Fernando de Mora
Participants:
– Marek Surowiec, Regulatory Affairs CMC Associate Director of mAbxience
– Isabel del Río, Deputy Director of BioSim (Spanish Biosimilar Association)
– Julie Maréchal-Jamil, Biosimilar Policy & Science director – Medicines for Europe
13:30 – 13:45h.
Forum Closure
Summary of key points from the forum
Fernando de Mora
Thanks to participants and speakers by the organizer
Jurgen Van Broeck
13:45h.
